The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
Abby Jones’ first stop of the day delivering medication was the home of 90-year-old Sarah Campbell Kier. “Come in!” yelled ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
The Iowa Pharmacy Association is calling for reform from Iowa lawmakers after 29 pharmacies closed last year, including some ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
A new FTC report blames Pharmacy Benefit Managers for marking up specialty drug prices, profiting $7.3 billion from cancer ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
That reality is the very reason that's prompting lawmakers to take action against Pharmacy Benefit Managers (PBMs) in hopes of preventing further economic strain on communities. A press conference ...
The bill is similar to Pennsylvania's new law and would curb PBMs by setting rules for rebates, audits and specialty drug ...